Last updated at 22 Jul 2024 05:11 PM
Director
DIN: 08027312
Indubala Pattanayak is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at RNBRITT LIFESCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08027312.Indubala Pattanayak has previously been associated with 1 company in roles such as Director.Indubala Pattanayak is currently involved in 2 different roles. Their most recent position is with RNB PHARMACEUTICALS INDIA PRIVATE LIMITED as a Individual Promoter. The first company Indubala Pattanayak was appointed to as a director was RNBRITT LIFESCIENCE PRIVATE LIMITED. Indubala Pattanayak has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Indubala Pattanayak is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at RNBRITT LIFESCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08027312.Indubala Pattanayak has previously been associated with 1 company in roles such as Director.Indubala Pattanayak is currently involved in 2 different roles. Their most recent position is with RNB PHARMACEUTICALS INDIA PRIVATE LIMITED as a Individual Promoter. The first company Indubala Pattanayak was appointed to as a director was RNBRITT LIFESCIENCE PRIVATE LIMITED. Indubala Pattanayak has a status of Deactivated. Please verify the details for any specific requirements or conditions.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RNBRITT LIFESCIENCE PRIVATE LIMITED | Director | 29-Dec-2017 |
| RNB PHARMACEUTICALS INDIA PRIVATE LIMITED | Individual Promoter | 27-Feb-2018 |